Constellation Brands stock under pressure as JPMorgan flags consumption and margin risks

EditorEmilio Ghigini
Published 2025-01-13, 05:32 a/m
STZ
-

On Monday, JPMorgan (NYSE:JPM) adjusted the outlook for Constellation Brands (NYSE:STZ) stock, downgrading it from 'Overweight' to 'Neutral'. Accompanying the downgrade, the price target was also reduced to $203 from the previous $262. The revision comes amidst a backdrop of both promising and challenging market conditions for the company.

The stock, currently trading at $181.81, has experienced significant pressure, falling over 18% in the past week. According to InvestingPro analysis, the stock's RSI suggests it is in oversold territory.

Constellation Brands, known for its Mexican beer portfolio and premium wine and spirits, has been recognized as one of the fastest-growing large-cap beverage companies in the United States. JPMorgan acknowledged the company's strengths, particularly its alignment with the premiumization trend and its appeal to the growing demographic of legal-drinking age Hispanic consumers.

The company maintains a solid financial position with a gross profit margin of 51.5% and has consistently raised its dividend for 10 consecutive years, currently offering a 2.2% yield. InvestingPro subscribers can access 10+ additional exclusive insights about Constellation Brands' financial health and market position.

Despite these positive factors, JPMorgan pointed out several headwinds facing Constellation Brands. The analyst cited concerns over sustained economic pressure on lower-income and Hispanic consumers, which could affect sales. Additionally, there is a potential decline in alcohol consumption among younger demographics, as well as risks stemming from a recent Surgeon General advisory that links alcohol use to cancer.

These concerns are reflected in the stock's performance, with a 29.4% decline over the past six months, now trading near its 52-week low of $179.55.

Other factors contributing to the more cautious outlook include the possible impacts from GLP-1 drugs, which are used for weight loss and may reduce alcohol consumption as a side effect, and the looming threat of tariffs. While the wine and spirits segments are expected to see organic growth and improved margins over time, the overall category trends remain subdued.

JPMorgan also noted that Constellation Brands has made efforts to enhance governance and capital allocation, which may lead to a more supportive shareholder base in the future. Despite the mixed outlook, these initiatives could have a positive impact on the company's performance going forward.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.